NCT06021340 What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
| NCT ID | NCT06021340 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | IVF |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-07-04 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-07-04 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.
Eligibility Criteria
Inclusion Criteria: * Patients attending the Assisted Reproductive Technology (ART) Unit of the Chinese University of Hong Kong for ART treatment. * Participant able to give voluntary, written, informed consent to participate in the study. Exclusion Criteria: * Patient using donor gamete in IVF treatment * Patient refuses to join and failed to giving consent for any reasons
Contact & Investigator
Yiu Leung D Chan, DPhil
PRINCIPAL INVESTIGATOR
CUHK
Frequently Asked Questions
Who can join the NCT06021340 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying IVF. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06021340 currently recruiting?
Yes, NCT06021340 is actively recruiting participants. Contact the research team at drdcyl16@cuhk.edu.hk for enrollment information.
Where is the NCT06021340 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06021340 clinical trial?
NCT06021340 is sponsored by Chinese University of Hong Kong. The principal investigator is Yiu Leung D Chan, DPhil at CUHK. The trial plans to enroll 50 participants.